News and Announcements
LifeArt offering diversified business opportunities to print market
- Published March 04, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- LifeArt, the founders and manufacturers of environmentally friendly, cardboard coffins are offering print market leaders the opportunity to diversify their business.
- LifeArt created the world’s first environmentally friendly, fully personalised, affordable enviroboard cremation coffin.
- LifeArt are seeking print group partners to lead their UK expansion to fuel local supply.
LifeArt, the founders and manufacturers of environmentally friendly, cardboard coffins are offering print market leaders the opportunity to diversify their business. 600, 000 coffins made in the UK alone every year, with 85% used for cremation services. The result is potentially carcinogenic dust and large amounts of waste and biomass fuel.
In response, LifeArt created the world’s first environmentally friendly, fully personalised, affordable enviroboard cremation coffin. Compared to standard cremation coffins, they use 80% fewer trees and emit 87% less nitrous oxide. They are engineered to surpass all weight bearing standards offering a sturdy yet lightweight alternative to standard particle board or MDF.
LifeArt are currently on a global expansion path with a recently opened global innovation centre based in Gloucester in the UK. Partnering with Agfa Graphics, LifeArt has installed an Agfa Jeti Mira LED wide format press into the new facility with all artwork colour matched by the Agfa Asanti workflow. This allows the customer to completely customise their chosen coffin with a graphic of their choice at an affordable price.
UK LifeArt Managing Director, Simon Rothwell, has established partnerships with print groups in Europe and is now seeking print group partners to lead their UK expansion. LifeArt are seeking local print businesses to supply the UK market. LifeArt provide their supply chain and technology whilst the printers print, cut, wrap, glue and assemble the coffins for local supply.
As the only environmentally-friendly, fully customisable coffin provider on the market, LifeArt are committed to dominating the space across the globe.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
